This Government Contract opportunity from Department Of Health And Human Services was posted on May 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Purchase Order for Metabolism-Qualified Cryopreserved Human Hepatocytes

Closed

CDER-2026-132690Federal

Submission Closed05/29/2026, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414

New

Federal

Ion AmpliSeq reagentsThe contract pertains to the procurement of Ion AmpliSeq reagents, with solicitation number 75N98026Q00637, issued by the National Institutes of Health under the Department of Health and Human Services. The notice, classified as a presolicitation, was posted on June 16, 2026, and specifies a response deadline of June 25, 2026. The procurement falls under the NAICS code 325414, indicating that it involves pharmaceuticals manufacturing. There is no set-aside designation applied to this contract, meaning it is open to all eligible bidders without reserved preference categories. The primary point of contact for this opportunity is David Shen, who can be reached via email. The contract office responsible for this solicitation is located in Bethesda, Maryland, with the performance site specified as Rockville, Maryland. The overall acquisition aims to secure Ion AmpliSeq reagents necessary for the agency’s research or operational needs, supporting activities related to health and biomedical research. Interested parties are directed to review detailed information and submit responses through the official federal contracting portal.

National Institutes Of Health Olao

POSTED

DEADLINE

Consumer Health & Wellness Product IntegrationThe contract involves the development of an over-the-counter or wellness version of an immune enhancer spray intended for consumer use, specifically targeting cold and flu seasons or periods of high exposure to illnesses. It is categorized as a subcontract under the NAICS code 325414, which pertains to pharmaceutical preparation manufacturing. The project is managed by a contractor associated with the Department of Energy, with the place of performance identified as Los Alamos, zip code 87545. Issued on June 15, 2026, the contract sets a response deadline of December 16, 2026, allowing for a six-month period for proposal submissions or other required actions. Although the solicitation number and specific agency office address are not provided, the contract is linked to Triad, a DOE contractor organization. This work aims to integrate a consumer health and wellness product into the market, emphasizing immune support during times when viral exposure is heightened.

Triad - DOE Contractor

POSTED

DEADLINE

ImmunoFecal Occult Blood (iFOB) and 10% KOH Test KitsThis contract involves the supply of ImmunoFecal Occult Blood (iFOB) test kits and 10% potassium hydroxide (KOH) test kits used for gastrointestinal and fungal diagnostic testing. The contract is a subcontract opportunity issued by the Navajo Area Indian Health Service, a division of the Department of Health and Human Services. The performance location is specified as Chinle, with the associated zip code 86503. The solicitation was posted on June 12, 2026, with a response deadline of June 27, 2026. The procurement falls under the NAICS code 325414, indicating it pertains to pharmaceutical and medicine manufacturing-related supplies. No specific set-aside type or organization details were provided, and the contract invitation does not list a designated point of contact. The focus is on supplying medical diagnostic kits essential for preventing and diagnosing gastrointestinal and fungal infections within the service area.

Navajo Area Indian Health Svc

POSTED

DEADLINE

Viral Transport Media (VTM) SupplyThis contract involves the supply of viral transport media (VTM) designed for preserving specimens used in microbiology and serology testing. The contract specifies the provision of both cold chain and ambient-stable options, ensuring flexibility in storage and transportation to maintain specimen integrity. The solicitation for this subcontract was posted in June 2026, with a response deadline set for late June 2026. The contract falls under the NAICS code 325414, which pertains to pharmaceutical and medicinal chemical manufacturing. It is issued by the Navajo Area Indian Health Service, part of the Department of Health and Human Services, with the place of performance located in Chinle, identified by the zip code 86503. The contract supports healthcare-related operations within this community, emphasizing reliable supply and quality control necessary for accurate laboratory testing.

Navajo Area Indian Health Svc

POSTED

DEADLINE

QC and Test Kits for Point-of-Care DevicesThis contract pertains to the supply of quality control and test kits designed to be compatible with multiple point-of-care diagnostic devices, specifically MedTox, Abbott ID Now, Triage Meter, and DCA 2000. The contract is classified under the NAICS code 325414, related to pharmaceutical preparation manufacturing, and is issued by the Navajo Area Indian Health Service, a division of the Department of Health and Human Services. The procurement is structured as a subcontract and focuses on supporting point-of-care diagnostic testing in healthcare settings. The contract posting date is June 12, 2026, with a response deadline set for June 27, 2026. The place of performance is identified as Chinle, zip code 86503. Details such as the solicitation number, type of set-aside, and specific contact information are not provided. The purpose of this contract is to ensure the availability of reliable and accurate quality control materials and test kits that facilitate diagnostic testing in clinical environments, improving patient care outcomes in the Navajo Area.

Navajo Area Indian Health Svc

POSTED

5 days ago

DEADLINE

in 11 days

AI Contract Overview

The FDA plans to award a sole source, firm-fixed-price purchase order to BioIVT, LLC for the supply of metabolism-qualified cryopreserved human hepatocytes needed to support ongoing FDA research. BioIVT is identified as the only capable source meeting specific donor requirements, viability, and metabolic activity standards essential for this study. A prior sources sought notice received no other vendor responses, justifying this sole source award under federal acquisition regulations. The procurement follows simplified acquisition procedures for commercial products under FAR Part 12, with NAICS code 325414 for Biological Product Manufacturing. Deliverables include four distinct female donor lots of cryopreserved human hepatocytes totaling 24 vials, each with high post-thaw viability, spanning donor ages 20-35 and 54-70 years. Additionally, culture media, an antibiotic reagent, appropriate cryogenic shipping, and full technical documentation including certificates of analysis and handling protocols must be provided. Delivery is required within seven days of contract award. Interested parties had the opportunity to respond by May 29, 2026, though this notice does not constitute a competitive solicitation. The FDA retains discretion over whether to pursue competition based on any responder's capability statement.

General Info

FDA awards sole source contract to BioIVT for cryopreserved human hepatocytes, 24 vials, seven-day delivery.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing View NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 20

special-notice

Response DeadlineMay 29

Deadline has passed

Submission Closed

05/29/2026, 09:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs

Contacts1 person available

OfficeRockville, MD, 20852, USA

Organization / Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Office AddressRockville, MD, 20852, USA

Contacts

Craig Wright

contact@example.gov

Full Description

The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed-price commercial Purchase Order (PO) to BioIVT, LLC (BioIVT), 1450 South Rolling Road, Baltimore, MD, 21227, for the Purchase of Metabolism-Qualified Cryopreserved Human Hepatocytes in accordance with the authority under FAR RFO Part 6.103-1 , Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

BioIVT is the only known source capable of providing metabolism-qualified cryopreserved human hepatocytes meeting the required donor characteristics, viability thresholds, and metabolic activity specifications necessary to support continuity of the FDA research study. A Sources Sought notice was previously posted on SAM.gov and no capability statements or responses were received from interested vendors.

This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services.

The North American Industry Classification System (NAICS) code for the proposed acquisition is 325414; Biological Product (except Diagnostic) Manufacturing, with a small business standard size of 1,250 employees.

Deliverables

The contractor shall provide up to 4 distinct female donor lots totaling 24 vials of cryopreserved human hepatocytes. Delivery must occur within 7 days of award.

Cryopreserved Human Hepatocytes – Donor Lot 1: Single-donor female metabolism-qualified cryoplatable human hepatocytes (Age 20–35 years), minimum viable cells/vials with >85% post-thaw viability — 6 Vials
Cryopreserved Human Hepatocytes – Donor Lot 2: Single-donor female metabolism-qualified cryoplatable human hepatocytes (Age 54–70 years), minimum 5 million viable cells/vials with >85% post-thaw viability — 6 Vials
Cryopreserved Human Hepatocytes – Donor Lot 3: Single-donor female metabolism-qualified cryoplatable human hepatocytes (Age 54–70 years), minimum 5 million viable cells/vials with >85% post-thaw viability — 6 Vials
Cryopreserved Human Hepatocytes – Donor Lot 4: Single-donor female metabolism-qualified cryoplatable human hepatocytes (Age 54–70 years), minimum 5 million viable cells/vials with >85% post-thaw viability — 6 Vials
Cell Culture Media – INVITROGRO HI Medium: 250 mL bottles — 2 Bottles
Cell Culture Media – INVITROGRO CP Medium: 250 mL bottles — 2 Bottles
Antibiotic Reagent – TORPEDO Antibiotic Mix 22 mL — 1 Bottle
Shipping Requirement: Domestic cryogenic shipping container/cryoshipper for temperature-controlled delivery — 1 Each
Technical Documentation – Certificate of Analysis (COA): Donor characterization information for each donor lot — 4 COAs
Technical Documentation – Protocols: Thawing, plating, culturing, and media preparation protocols in PDF format — 1 Complete Protocol Package

Responses

Responses to this notice should be sent to Shavone Jeter at shavone.jeter@fda.hhs.gov no later than 5:00 pm (ET) on May 29, 2026. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.